Key Studies Influencing My Practice Following Washington 2017

October 20-24, 2017; Washington, DC
Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed.
Format: Audio (.mp3)
File Size: 46.24 MB
Released: November 20, 2017

Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed. (50 minutes)

Stephen A. Harrison, MD, COL (Ret.), FAASLD, has disclosed that he has received consulting fees from Axcella, Capulus, the Chronic Liver Disease Foundation, Cirius, Genfit, Echosens, Histoindex, Intercept, Madrigal, NGM Bio, Novartis, Novo Nordisk, Perspectum, and Prometheus; has received fees for non-CME/CE services from AbbVie, Alexion, and Gilead Sciences; and has an ownership interest in Cirius.

Paul Y. Kwo, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck and funds for research support from AbbVie and Gilead Sciences.

Norah Terrault, MD, MPH, has disclosed that she has received consulting fees from Gilead Sciences and Merck and funds for research support from AbbVie, Gilead Sciences, and Merck.

Acknowledgements

Educational grant provided by:
AbbVie
Gilead Sciences
Merck & Co., Inc.

Related Content

Audio commentary from Dr. Robert Brown on when to treat chronic hepatitis B, what drugs to use, and when to consider stopping HBV therapy.

Robert S. Brown, Jr., MD, MPH Released: August 14, 2019

TasP commentary from Alessio Aghemo, MD, PhD, on improving PWID access to HCV treatment by changing restrictive regulatory barriers in Italy

Alessio Aghemo, MD, PhD Released: August 2, 2019

CME/CE/CPE-certified video on strategies for bringing HCV cure to more patients, led by Nancy Reau, MD, from the CCO Hepatitis Annual Meeting

Ira M. Jacobson, MD
Program Director
Jordan J. Feld, MD, MPH Paul Y. Kwo, MD Marion G. Peters, MD, FRACP Nancy Reau, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: August 1, 2019 Expiration: July 31, 2020

Expert commentary from W. David Hardy, MD, featuring guidance on HCV screening and treatment as prevention in MSM, provided by Clinical Care Options

W. David Hardy, MD Released: July 18, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?